Tatva Chintan Pharma Chem Ltd
NSE:TATVA

Watchlist Manager
Tatva Chintan Pharma Chem Ltd Logo
Tatva Chintan Pharma Chem Ltd
NSE:TATVA
Watchlist
Price: 843.1 INR 3.71% Market Closed
Market Cap: 19.7B INR
Have any thoughts about
Tatva Chintan Pharma Chem Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Tatva Chintan Pharma Chem Ltd

Current Assets 2.5B
Cash & Short-Term Investments 154.4m
Receivables 729.8m
Other Current Assets 1.6B
Non-Current Assets 5.6B
Long-Term Investments 42.2m
PP&E 5.4B
Intangibles 35.1m
Other Non-Current Assets 137.1m
Current Liabilities 678.2m
Accounts Payable 266m
Other Current Liabilities 412.2m
Non-Current Liabilities 15.9m
Long-Term Debt 2.6m
Other Non-Current Liabilities 13.3m

Balance Sheet
Tatva Chintan Pharma Chem Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
157
108
53
630
274
353
Cash
81
82
47
251
259
205
Cash Equivalents
76
26
7
379
15
148
Short-Term Investments
90
11
11
8
139
104
Total Receivables
435
516
926
694
968
881
Accounts Receivables
413
496
907
572
876
724
Other Receivables
22
20
19
123
92
158
Inventory
356
636
720
1 700
1 625
1 528
Other Current Assets
106
57
131
1 327
118
113
Total Current Assets
1 144
1 327
1 843
4 359
3 123
2 979
PP&E Net
726
1 160
1 302
2 108
4 265
5 031
PP&E Gross
0
0
0
2 108
4 265
5 031
Accumulated Depreciation
0
0
0
262
351
604
Intangible Assets
1
1
1
3
5
4
Other Long-Term Assets
4
2
3
113
196
174
Total Assets
1 875
N/A
2 489
+33%
3 148
+26%
6 583
+109%
7 589
+15%
8 187
+8%
Liabilities
Accounts Payable
221
316
475
445
322
450
Accrued Liabilities
0
0
0
65
51
76
Short-Term Debt
399
405
493
925
1 562
100
Current Portion of Long-Term Debt
57
115
142
144
98
36
Other Current Liabilities
49
41
71
136
354
134
Total Current Liabilities
727
877
1 180
1 714
2 387
797
Long-Term Debt
315
387
268
131
42
6
Deferred Income Tax
33
45
21
0
0
0
Other Liabilities
3
4
20
7
11
13
Total Liabilities
1 078
N/A
1 312
+22%
1 488
+13%
1 852
+24%
2 441
+32%
816
-67%
Equity
Common Stock
80
80
201
222
222
234
Retained Earnings
716
1 094
1 456
2 413
2 822
3 077
Additional Paid In Capital
0
0
0
2 090
2 090
4 044
Other Equity
0
2
3
6
14
16
Total Equity
797
N/A
1 177
+48%
1 660
+41%
4 731
+185%
5 148
+9%
7 371
+43%
Total Liabilities & Equity
1 875
N/A
2 489
+33%
3 148
+26%
6 583
+109%
7 589
+15%
8 187
+8%
Shares Outstanding
Common Shares Outstanding
22
22
22
22
22
23

See Also

Discover More